Intervention not reported
Generic waiting list · patients needing elective specialist ambulatory visit or surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Neuropsychiatric symptoms Measured using NPI. Severity of symptoms is measured on a scale of 0‐144. A higher score indicates worse symptoms · people with dementia
1 finding from 1 review
Intervention not reported
Drug use (generic percentage)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
ACR 50% improvement · patients with rheumatoid arthritis
Rituximab (2 x 1000 mg) plus methotrexate probably leads to higher clinical improvement American College of Rheumatology 50%… compared with methotrexate monotherapy (moderate certainty).
1 finding from 1 review
Blood loss in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Red cell transfusion requirement in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
It is very uncertain whether lidocaine changes ventricular fibrillation compared with disopyramide (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): cardiac blocks (high‐degree atrioventricular block and bundle) · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): cardiac blocks… compared with disopyramide (very low certainty).
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
It is very uncertain whether lidocaine changes ventricular fibrillation compared with mexiletine (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): atrioventricular block · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): atrioventricular block compared with mexiletine (very low certainty).
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
It is very uncertain whether lidocaine changes ventricular fibrillation compared with propafenone (very low certainty).
1 finding from 1 review
Neuropsychiatric adverse event · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): neuropsychiatric… compared with propafenone (very low certainty).
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
It is very uncertain whether lidocaine changes ventricular fibrillation compared with amiodarone (very low certainty).
1 finding from 1 review
Ventricular fibrillationElectrocardiogram · patients with acute myocardial infarction
Lidocaine showed no clear difference in ventricular fibrillationElectrocardiogram compared with placebo or no intervention (low certainty).
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive performance on psychometric tests · Participants with chronic cognitive impairment in traumatic brain injury
1 finding from 1 review
Pain A 0 t o 100 visual or numerical scale, where 0 equals no pain at all and 100 is the worst pain imaginable · patients with non‐specific low‐back pain (LBP)
1 finding from 1 review